Medocaine (Lidocaine Hydrochloride)

Lidocaine blocks voltage‑gated sodium channels on nerve membranes, preventing the rapid influx of sodium that initiates action potentials. This stabilises the neuronal membrane and stops nerve impulse transmission, resulting in a temporary loss of sensation in the area where the drug is applied.

The dose of Medocaine is determined by the prescribing clinician based on the specific procedure, patient weight, age, and clinical condition. Dosage guidelines are provided in the product’s prescribing information, and the prescriber tailors the amount to achieve adequate anesthesia while minimising toxicity.

Safety data for lidocaine in pregnancy and lactation are limited. It is classified as a Category C drug in many regions, meaning risk cannot be ruled out. Use only if the potential benefit justifies the potential risk to the fetus or infant, and always under medical supervision.

To order Medocaine, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and required import documentation.

Both lidocaine (Medocaine) and bupivacaine are amide‑type local anesthetics, but lidocaine has a faster onset and a shorter duration of action, making it suitable for short‑procedures. Bupivacaine provides longer‑lasting analgesia but carries a higher risk of cardiotoxicity at comparable doses.

Medocaine should be stored below 25 °C in its original packaging, protected from moisture and direct light. Keep the container tightly closed, and avoid freezing. Handling should be performed using aseptic technique to prevent contamination before administration.

Medocaine is administered by a qualified healthcare professional via epidural, infiltration or intraarticular injection. The solution is injected directly into the target tissue or space using sterile technique, and the volume and concentration are adjusted according to the clinical protocol.

The most serious risks include systemic toxicity leading to central nervous system seizures, cardiac arrhythmias or cardiac arrest, and severe allergic reactions such as anaphylaxis. Immediate monitoring of cardiovascular and neurological status is essential, especially after high‑dose or rapid administration.

Medocaine should be avoided in patients with known hypersensitivity to lidocaine or other amide‑type local anesthetics, in those with severe hepatic impairment, and in individuals receiving other sodium channel‑blocking agents that could increase toxicity. Caution is also advised for patients with significant cardiac conduction disorders.